Estuary is a biotechnology company developing genetic medicines for patients with serious kidney diseases.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/19/26	$103,000,000	Seed and Series A	4BIO Capital Biogen New Ventures Deep Track Capital GV National Kidney Foundation Pivotal bioVenture Partners RA Capital Management UPMC Enterprise	undisclosed